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ABSTRACT
Ribose 5 ' -phosphate Aminotransferase of Salmonella typhimurium
by
Gulamnabi Y. Vahora, Master of Science
Utah State University, 1971
Major Professor: Dr. Carl A. Westby
Department: Bacteriology and Public Health
Ribose-5 '-phosphate aminotransferase, an alternate first enzyme in the
purine de novo pathway, has been purified about 800-fold from Salmonella
typhimurium (pur D-55 ).

The enzyme is distinct from ribosylpyrophosphate-

5' -phosphate amidotransferase (E C 2. 4. 2.14), has an approximate molecular
weight of 229,000, and requires ribose-5'-phosphate, ATP and either ammonium
ion, carbamyl phosphate or L-glutamine, to synthesize 5'-phosphoribosylamine
(PRA).

A coupled assay system, employing a§_. typhimurium (pur G-310) ex-

tract as the coupling-agent source, was used to measure the enzyme.

PRA pro-

duction in this system was inhibited by higher ribose-5' -phosphate concentrations
and longer (over 10 minutes) incubation periods.

It is proposed that an alternate

pathway for the initial step of purine biosynthesis exists in§_. typhimurium,
namely, the direct conversion of ribose-5 '-phosphate and ammonium ion to PRA.
(50 pages)

INTRODUCTION

Free purine and pyrimidine nucleotides are present intracellularly in
all forms of life and serve as major components of nucleic acids as well as
many co-enzymes .

The study of the biosynthesis of these compounds conse-·

quently has lead to an understanding of the universality of life.
One approach to the study of purine biosynthesis followed by a goodly
number of investigators (1, 5, 8, 24, 34, 36, 60) has been to examine the
enzymes of the pathway.

Perhaps the first-step enzyme, PP-ribose-P amido-

transferase, has received the most attention in this regard because of its
dominant role in regulation of the pathway.
This study, on the other hand, reports on an alternate first enzyme of
the pathway, ribose-5 '-phosphate aminotransferase, catalyzing the reaction:
+

Ribose-5 '-phosphate + NH + ATP
4

Phosphoribosylamine (PRA) +

ADP + Pi

The aminotransferase was purified from the cell-free extract of a
S. typhimurium mutant (Pur D- 55) lacking the second de novo enzyme,
(glycinamide ribotide synthetase) GAR synthetase,

and various of its physical

and biochemical properties were examined . The results of the study confirm
the assertions of earlier investigations on the existence of an alternate first

2

enzyme.

The significance of non-enzymatic PRA formation (45) in

§_. typhimurium now must be re-examined in light of the present study .
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REVIEW OF LITERATURE

The 12&, Novo Synthesis of Purine Nucleotides

In the past four decades great numbers of investigators have labored
to elucidate the biosynthesis of purine nucleotides in avian (22, 48 , 64), tumor
(26, 29), plant (32), and microbial systems ( 1, 12, 17, 34, 43, 51, 56, 60).
If it were not for the early emphasis that was given to studies on avian liver,
microorganisms might have played a more prominent role in the initial discoveries on purine biosynthesis because purine auxotrophic mutants of bacteria
were available early and could have been gainfully employed in Beadle-Tatum
(2) types of biosynthetic analyses. As it happened, however, the first studies
of purine biosynthesis were in avian liver systems, the most important of these
being the works of Schuler and Reindel (53) in 1935, and Edson et al. (11) and
Orstrom et al. (47) in 1936 and 1939, respectively.

The particularly important

effort of Krebs and coworkers to synthesize purines de novo in pigeon liver
slices was the first synthetic study of the pathway at the in vitro level.
Hypoxanthine was produced in vitro for the first time in this study, and its
synthesis was stimulated by oxaloacetate and L-glutamine (47), suggesting that
the nitrogen base was being formed de novo rather than as a result of a breakdown of a pre-formed purine.
The first tissue and cell free system capable of carrying out hypoxanthine
synthesis was constructed by Greenberg (18), using pigeon liver extract.

His

4

results indicated that inosinic acid was the first purine compound formed and it
was then further catabolized to inosine, hypoxanthine, or uric acid.

The work

of Greenberg (18, 19) also s uggested that purine bases were synthesized from
simpler phosphoribosyl derivatives such as ribose-5 '-phosphate.
The incorporation of radioactivity into uric acid from labeled CO ,
2
formate and glycine in in vivo studies (7, 8, 20, 57, 58) indicated that carbon 6
of uric acid was derived from CO , carbon 2 and 8 from formate and carbon 4,
2
5, and nitrogen 7 from, respectively, the carboxyl carbon, the CX carbon and
the nitrogen atom of glycine (Figure 1).

Because of the rapid interchange and

15
15
loss of N from N labeled compounds in the body pools of pigeons, the
origin of nitrogen atoms 1, 3, and 9 of uric acid could not be definitely determined by in viv~ studies . Levenberg et al. (36) were able to establish the exact
origins of these nitrogen atoms, however, by analyzing the degradation products
of uric acid and it was ascertained that nitrogen 1 was derived from aspartic
acid, and nitrogen atoms 3 and 9 were derived from the amide nitrogen of
glutamine.
The other naturally occurring purines were thereafter shown to be
synthesized in a similar fashion (5).

Figure 1 summarizes the current state

of information.

.

The Formation of fl-D-Phosphoribosylamine (PRA)

The initial steps of de novo purine nucleotide synthesis were largely
worked out by Goldthwait (13), Goldthwait et al. (14), Levenberg et al. (36),

RIBOSE-5 - PHOSPHATE

Figure 1.

The origin of the carbon and nitrogen atoms of the purine, inosinic acid.
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Buchanan and Hartman (6), Hartman and Levenberg (25), Lukens and Flaks (3 8),
and Greenberg (18, 19), in in vitro av ian liver studies of the 1950's.
Kornberg et al. ( 33), and Remy et al. (50), suggested from their studies
that the purine biosynthetic pathway was initiated by the formation of 5'-pho s phoribosylpyrophosphate (PP - ribose- P) from ribose-5'-phosphate and AT P
through the mediation of 5 ' -phosphoribose-pyrophosphokinase (EC 2.7.6 . 1).
The formation of j?-D-phosphoribosylamine (PRA) from PP-ribos e -P and
L-glutamine was shortly thereafter shown to be the next reaction (22, 26, 49),
however, recently an a lternate synthesis of PRA from ribose-5' -phosphate and
ammonium ion was demonstrated in some of the same systems (29, 32, 34, 45,
48), thus revealing a previously undetected convergence in the de nova pathway.
Details of the alternate routes to PRA are indicated in equations 1 and 2.

1.

PP-ribose-P
ribosylpyrophosphate 5 '-amidotransferase )
(EC 2· 4· 2. 14)

+

PRA + PP +
L-glutamate

L - glutamine

2. Ribose-5 '-phosphate
+
+ NH + ATP
4

PRA + ADP
ribose - 5'-phosphate aminotransferase> + Pi + H o
2

Ribo sy lpyropho sphate 5 '-Amidotr ansf er as e

The PP-ribose-P amidotransferase mediated formation of PRA from
PP-ribose - P, L-glutamine, -magnesium ion, and ATP is evidenced in plant
(32), animal (26, 29, 30, 49), avian (5, 9, 22, 64) and bacterial systems (17,
43, 51, 56).

The amide group of L-glutamine seems to serve as the primary

7

amino source of PRA in pigeon liver (22, 24) and bacteria (17, 43, 51, 56),
whereas in plants (32) (wheat embryo) the amide group of L-asparagine serves
this role.
The amidotransferase has been purified from pigeon liver (9, 21, 22)J
ascites tumor (4, 35) and Aerobacter aerogenes (43) approximately 1000-,
20- and 12-fold, respectively.

The avian liver enzyme has a molecular weight

of about 200,000, contains non-heme iron (9, 21) and has a sedimentation
coefficient of 9 S (9 to 11 S for crude enzyme preparation). Rowe and Wyngaarden
(52) have reported that the enzyme dissociates rapidly into 100, 000 molecular
weight subunits and that these, in the presence of thiols, dissociate into 50, 000
molecular weight subunits or monomers, which are identical electrophoretically.
Each 100,000 molecular weight subunit or dimer, contains 6 non-heme iron
atoms, some of which are involved in the catalytic reaction and some of which
serve primarily a structural function.

The visible absorption spectrum of the

enzyme reveals a maximum at 415 m}1, which disappears with the removal of
iron from the protein.
The pigeon liver enzyme contains two separate regulatory sites, one
for 6-amino and one for 6-hydroxy purine ribonucleotides (22, 23).

Mixtures

of two non-homologous types of purine ribonucleotides affect a cooperative
inhibition on the enzyme (22, 23).

It is postulated that the purine ribonucleotides

function as allosteric regulators, binding at sites on the enzyme molecule
distinct from the active site and inducing a conformational change in the enzyme
that renders it catalytically less effective by reducing its substrate affinity (59).

8

Ribose-5' -Phosphate Aminotransferase

The direct enzymatic synthesis of PRA from ribose-5'-phosphate, ATP
and ammonium ion was first suggested by the work of Nierlich and Magasanik in
bacterial studies involving A. aerogenes (43).

Later the same authors concluded

from other evidence that the PRA synthesis they were observing was completely
non-enzymic (45), and the ATP requirement was an artifact.

Le Gal and co-

workers (34) in Escherichia coli studies have since presented opposing evidence,
suggesting that PRA is synthesized in vivo from ribose-5'-phosphate and
ammonium ion, for the most part, through an enzyme reaction.

Other workers

also have evidence of such an enzymic synthesis of PRA in other systems (12,
27, 28, 29, 32). Reem (48), for example, h as shown that the alternate synthesis
of PRA in avian liver occurs only when ribose-5'-phosphate, ATP, magnesium
ion, an ammonium ion donor, and an enzyme which is separate and distinct
from PP-ribose-P amidotransferase are present.

Furthermore, the demon-

stration of a feed-back sensitivity suggests that the enzymes' role is similar
to that of PP-ribose·- P amidotransferase in the regulation of purine biosynthesis.
The involved enzyme, termed "ribose-5' - phosphate aminotransferase," was
purified by Reem approximately 100-fold from duck, chicken, and pigeon liver,
and it demonstrated only half the activity of the liver amidotransferase (per
mg protein), and was subject to a substrate inhibition by ribose-5'-phosphate.
Gandhi and Westby (12) first reported evidence of the aminotransferase
in S. typhimurium.

They observed an in vitro synthesis of PRA from ribose-5 ' -

phosphate and NH Cl in a system containing a partially purified extract of GAR
4
synthetase.

Their work has given impetus to the present study.

9

The enzymatic synthesis of PRA from ribose-5'-phosphate and NH Cl
4
may be of general biological importance because it could provide an alternate
means for a typical cell to produce PRA for the de novo synthesis of purines
and other end products of the pathway (e.g., thiamine, riboflavin).

In Ehrlich

ascites cells (29), for example, it appears that the alternate route is indeed
operative in vivo and, in fact, is quantitatively more important than the classical
route.

In gout-ridden and leukemic cells presumptive evidence indicates an

increased rate of de novo purine biosynthesis (20, 49, 55).

The answer to the

larger question, "which route to PRA is more important in other biological
systems ? , " would depend among other things on which enzyme was present in
greatest concentration, the substrate Km values, and which enzyme was most
subject to feed - b ack inhibition by the end products.

Information on these points

is limited, but in regard to the last item both enzymes have been shown to be
extremely sensitive to purine nucleotides in various systems (9, 16, 49).

/J-D-Phosphoribosylamine (PRA) and Its Conversion to GAR

)]-D -phosphoribosylamine, the reaction product of both PP-ribose - P
amidotransferase and ribose-5' -phosphate aminotransferase has not yet been
isolated in any in vivo or in vitro systems because of its considerable instability.
The amine has been prepared chemic ally, however, by the re action of ribose5' -phosphate with liquid ammonia under anhydrous conditions (38), and partially
purified as the barium, calcium, or potassium salt. Absolute chemical characterization has been difficult because of the presence of unreacted ribose-5' phosphate and ammonia in the chemically made preparations and the tendency for

10
the compound to break down.

It has been satisfactorily preserved for periods

of several weeks by storage in 0. 02 N KOH at low temperatures (38).
In the de novo purine pathway, PRA is converted to glycinamide ribotide
(GAR).

This conversion was first shown in pigeon liver studies by Goldthwait

(13) and Goldthwait et al. (14) and it was subsequently confirmed by Hartman and
Buchanan (22), the details are summarized in equation 3.

3·

RA
p

+

Gl

.
AT Ribosylamine-5' - phosphate:glycine ligase )
ycme +
p (EC 6·3 · 1.3)
GAR + ADP + Pi

The enzyme mediating the reaction, trivially termed GAR synthetase, has been
purified from pigeon liver (22), A. aerogenes (45) and~- typhimurium (12).

The

reaction is reversible and the reaction mechanism has been described in detail
by Hartman and Buchanan (23).

An equilibrium constant for the reaction could

not be obtained because of the apparent destruction of PRA, however, the conversion of GAR to PRA is favored over its synthesis from PRA because of the
instability of PRA which pulls the reaction in the direction of PRA.
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MATERIALS AND METHODS

Chemicals

D-ribose-5' -phosphate as the sodium salt was obtained from the Mathe son
Company, glycine-2-

14

c came from New England Nuclear Corporation, while

hemoglobin (Sigma type 1) and beef liver catalase were gifts from Dr. B. F.
Burnham (Utah State University).

Cellex-D (DEAE cellulose) was purchased

from Bio-Rad Laboratories, and the other resin, Dowex-50-H+ (200 to 400 mesh,
8% cross linkage), was a gift of the Dow Chemical Company.

+

Dowex-50-H was

converted to the ammonium ion form by a standard procedure.

Growth of Bacteria

The two purine requiring strains of ~- typhimurium employed in the
studies were pur D-55 and pur G-310.

Both were obtained from the working

collection of Dr. J. S. Gots (University of Pennsylvania). Pur D-55 lacks GAR
synthetase (63) and is consequently unable to convert PRA to GAR (equation 3
in literature review, p. 10 of this thesis), and pur G-310 lacks a later enzyme
(63), formyl-GAR amidotransferase (EC 6. 3. 5. 3) and is consequently unable to
convert formyl-GAR to 5 '-phosphoribosyl-N-formylglycinamidine. Inocula of the
two strains were prepared by placing overnight nutrient broth cultures of each
at a 1:100 dilution into vessels containing the E medium (500 ml) of Vogel and
Bonner (62) supplemented with glycerol (0. 2% W/V) , thiamine (1. 0 pg/ml) and

12
0

monosodium xanthine (2. 5 p-g/ml) and incubating the flasks at 37 C with bubbling
aeration for 10- 12 hr.
Sixty liter batches of bacterial cells for use in enzyme purification
were prepared by inoculating 5 gallon carboys (4 carboys) containing the
supplemented E medium with the 10- 12 hr. · inocula (1 :100 dilution), incubating
the vessels at 37°C with bubbling aeration for 12 hr., and harvesting the cells
by centrifugation at 3° C.

After centrifugation, the cells were washed with

1 liter of 0. 005 M sodium phosphate buffer, pH 7. 0, and then were frozen over night in a small amount of the same buffer made 2. 0 mM with respect to
2-mercaptoethanol (e.g., 45 gm wet weight cells suspended in 50 ml of buffer) .

Preparation of Extracts

Cell-free extracts were prepared by rupturing thawed cells with a
Bronwill homogenizer (Type 2876, Bronwill Scientific Inc., Rochester,
New York), using the method of Doughty and Mann (10).

Good cell breakage

coupled with a satisfactory recovery of ribo se-5 '-phosphate aminotransferase
activity was obtained when the homogenization schedule consisted of two,
4000- cycle 2 min. runs.
Crude extract was separated from unbroken cells and debris by centrifugation at 52,000 x g for 20 min. at

o0 c.

The protein content of crude and

purified extracts was determined by the method of Lowry et al. (37).
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Purification of Ribose-5' -Phosphate Aminotransferase

A crude, cell-free extract of£· typhimurium, strain pur D-55, prepared as described above, was used in a purification scheme to obtain a ribose5' -phosphate aminotransferase, free of many other enzymes.

The initial

purification techniques which were used generally follow the procedures employed
by Reem (48) in her purification of an avian liver ribose-5 '-phosphate aminotransferase.

All steps were carried out at 4°C and all buffers contained 2. 0 mM

2-mercaptoethanol unless otherwise stated.
Ammonium sulfate fractionation.

Fifty-two milliliters of crude extract

prepared as described above were fractionated with 24. 5 gm (NH ) SO to pro4 2
4
duce 70% saturation.

The 0-70% fraction lacked aminotransferase activity, how-

ever, substantial activity was present in the supernatant (50 ml and 1. 85 mg
protein per ml) which was dialyzed for 7 hr. against 4. 5 liters of 0. 005 M
sodium phosphate buffer, pH 8. 0, to remove the (NH ) SO (fraction I).
42 4
DEAE cellulose chromatography. A 52 ml portion of the dialyzed extract was placed on a DEAE cellulose column (2. 5 x 10 cm) previously
equilibrated with 0. 005 M sodium phosphate buffer pH 7. 0 at 5°C.

The column

was washed with 20 ml of the same buffer followed by a 600 ml step-wise
gradient of decreasing pH and increasing molarity.

The gradient was generated

with a gradient mixing device, having two side-by-side chambers of equal
diameter.

The mixing chamber initially contained 300 ml of 0. 005 M sodium

phosphate buffer pH 7. 0 and the reservoir chamber, 300 ml of O. 05 M sodium
phosphate buffer pH 6. 0.

Ten milliliter fractions were collected from the

14
column after 72 ml of liquid lacking activity had been eluted. When 100 ml more
had eluted, the reservoir chamber was made 0. 08 M with respect to KC1(14. 8
gm).

Following this, eluates were collected as before.

From each fraction,

0. 2 ml and 0. 4 ml samples were removed for protein estimation and assay of
enzyme activity, respectively.

The fractions demonstrating the highest activity

(tubes No. 15 and 18, second peak fraction) were pooled (Fraction II).
Pressure dialysis. A 40 ml sample from the DEAE cellulose column
was added to a pressure dialysis chamber (Amicon Corporation, Diaflo model
200) fitted with a 10,000 molecular weight exclusion ultrafilter (Diaflo PM-10,
62 mm).

Nitrogen pressure of 20 psi was applied to the filter, to force the fluid

through the filter membrane. After most of the liquid had passed through the
filter, the retentate was washed with 20 ml of cooled water made 2. 0 mM with
respect to 2-mercaptoethanol.
dialysis.

The wash was removed by further pressure

The dialyzates (initial and wash) contained KCl and other salts

were discarded.

The retentate, in a final volume of 2-3 ml, contained all the

proteins of the purified extract.

The volume of the retentate was readjusted to

approximately 10 ml with cold water containing 2-mercaptoethanol (2. 0 mM)
and pressure dialysis was repeated with a 50,000 molecular weight ultrafilter
(Diaflo PM-50, 62 mm).

Most of the proteins, including the aminotransferase,

remained again in the retentate and after washing as above, the retentate (6 ml)
was subjected a third time to pressure dialysis, in this case with a 100, 000
molecular weight ultrafilter (Diaflo XM-100, 62 mm).

After the retentate was

washed a third time, an examjnation indicated the aminotransferase was still
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present in the retentate which had a volume of 7 ml and contained 160 pg
protein/ml.

This preparation was called fraction III.

In order to have sufficient purified enzyme for substrate tests,
molecular weight analyses and kinetic measurements, the fraction III extracts
from two similar purification runs were combined and concentrated by pressure
dialysis with a 10,000 molecular weight ultrafilter to a protein concentration of
200 pg/ml.

Assay of Ribose-5 '-Phosphate Aminotransferase (for PRA Production)

The aminotransferase catalyzing the ATP dependent conversion of
ammonium ion and ribose-5' -phosphate to PRA was assayed indirectly with a
coupled system owing to the instability of PRA under physiological conditions .
To accomplish the coupling, glycine- 2-

14

C and a partially purified GAR

synthetase preparation (0 . 6- 1. 0 mg protein of 0-40% (NH ) SO fraction of
4
4 2
~- typhimurium pur G-310 extract per assay mixture) were included in the assay
system thereby allowing the conversion of any unstable PRA to the stable
product GAR, according to equation 3 (in literature review, p. 10 of this thesis ).
The GAR synthetase preparation was not entirely free from ribose-5' - phosphate
aminotransferase , however, an appropriate control was set up in each assay
(except in the enzyme dosage experiment) to account for the small amount of
PRA produced from the aminotransferase contaminating the coupled system.
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A typical incubation mixture contained 30 ,.umoles tris-HCl buffer
(pH 9. 0), 1. 2 p.moles glycine-2-

14

c (0. 0809-0. 112 µc/µmole), 2. 7 µmoles

MgC1 , 1 p.mole ATP, 10 ¥moles NH Cl, 5 µmoles ribose-5'-phosphate and
4
2
the two enzyme fractions in a final volume of 0. 50 ml.
Control systems contained the same ingredients but were formulated
without the second enzyme fraction and thus lacked the aminotransferase.

The

mixtures (test and control) were incubated at 37°c for 10 min., at which time
0. 05 ml of 50% trichloroacetic acid was added to stop any reaction and to
precipitate the protein.
GAR-

14

c and any of the next de novo intermediate, formyl-GAR-

(mixtures termed "total GAR") were separated from unreacted glycine-2and measured by the method of Westby and Gots (63).

14

14

c

c

Modifications included

the use of 0. 5 x 7. 0 cm Dowex-50 ammonia columns rather than 0. 5 x 5. 0 cm
columns and elution of the "total GAR" from these columns with 8. 0 ml of
0. 1 N HCl wash rather than with only 3. 2 ml.

Specific activity was ascertained

from the amount of "total GAR" produced according to the method of Gandhi
and Westby (12).

The "total GAR" was assumed to be equivalent to the PRA.

Determination of Molecular Weight of Ribose-5' -Phosphate
Aminotransferase

An estimate of the molecular weight of the ribose-5' -phosphate aminotransferase of§_. typhimurium was determined by the sucrose gradient ultracentrifugation method of Noll (46).

Sucrose gradients were prepared in 0. 05 M

17
tris-HCl buffer, pH 7. 5, made 2. 0 mM with respect to 2-mercaptoethanol.
Bovine hemoglobin (0. 01 ml, 15 mg/ ml) or beef liver catalase (0. 01 ml containing 13. 5 mg protein/ ml) or both, as reference standards, were included
with the layered enzyme sample (0. 08 ml of fraction III containing 200 p-g
protein/ml) at the time of centrifugation.

Tubes were centrifuged on the Inter-

national Equipment Co., B-60 centrifuge with the SB-283 rotor (Model 488) at
0

40,000 rpm for 19 hr. at 3-4 C.
To determine the location of the aminotransferase and the catalase,
the centrifuged tubes were bottom punctured and six drop samples were collected and assayed for the aminotransferase by the method described above
and for catalase by a slight modification of the assay of Weil-Malherbe and
Schade (40).

The position of hemoglobin in centrifuged tubes was apparent

by its color.

From the position of the aminotransferase and the references,

it was possible to calculate the molecular weight of the aminotransferase
using the equations of Martin and Ames (41).
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RESULTS

Purification of Ribose-5' -Phosphate Aminotransferase

To ascertain whether the NH Cl and ribose-5'-phosphate dependent
4
synthesis of PRA observed by Gandhi and Westby (12) in§_. typhimurium was
enzymatic or non-enzymatic, an attempt was made to purify from the enterobacterium an enzyme that would catalyze the synthesis. Using the coupled
assay described earlier, an enzyme was detected in strain pur D-55 extracts,
which brought about the desired synthesis and whose specific activity increased
incrementally in extracts undergoing successive purification. A summary of
the purification procedure and the extent of purification of the aminotransferase
at various steps is given in Table 1.
The second step of purification, DEAE cellulose chromatography,
served more than the other steps to purify the ribose-5 '-phosphate aminotransferase.

The results of the DEAE cellulose chromatography, in terms of the

elution of total protein and the enzyme, are indicated in Figure 2.

Two peaks of

enzyme activity were observed.

Kinetic Studies

To ascertain the significance of non-enzymatic PRA formation (45) in
the assay system used in this study, increasing quantities of ribose-5' -phosphate
aminotransferase (from fraction III) were incubated in a series of otherwise

Table 1.

Purificati on of ribose- 5' - phosphate aminotransferase from

Stage and procedure

Protein

typhimurium

PRA as "total GAR"
(nanomoles / mg protein)

52. 00 ml

8. 00 mg/ ml

70

2. Ammonium sulfate

50. 00 ml

1. 85 mg/ ml

550

3.

DEAE cellulose

40. 00 ml

230 ,-ig/ ml

24. 6

X

4.

Pressure dialysis

10. oo· ml

2001,1g/ ml

55

10

1.

Crude

Volume

£·

X

Fold purification
1.0

7.92

10
3

3

Yield %
100

39.00

388

19.00

792

2.00

Figure 2. Elution of ribose-5 '-phosphate aminotransferase from DEAE
cellulose column. The procedur e is described in "Materials
and Methods. "
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identical incubation mixtures.

The amount of PRA produced in each of these

mixtures was proportional to the amount of enzyme present in that system
except where saturating levels of the enzyme were present (Figure 3).

This

suggested that the PRA was, in fact, being produced enzymatically. Extensive
dialysis would have removed any substrates from Fraction III, so the increased
synthesis of PRA could not be ascribed to anything but large molecules, supposedly protein, present in fraction III.

As can be noted in Figure 3, some

PRA was formed even in the absence of added aminotransferase.

This could

reflect either a non-enzymic synthesis of PRA or an enzymic synthesis from
small amounts of the aminotransferase contaminating the coupling agent.
The results from another kinetic experiment are indicated in Figure 4.
In this test identical incubation mixtures containing a constant level of the amino-

transferase, coupling agent and other assay ingredients were incubated for varying periods of time. After 10 min. incubation at 37°C, the amount of PRA that
was synthesized surprisingly decreased, and the decrease continued with
increasing incubation time.

From zero till 10 min. , the amount of PRA

synthesized was proportional to the time of incubation and it was only after
this, that the amount of product decreased.

The reason for the decline in PRA

production after 10 min. of incubation is unknown, but as a result of the experiment all assays were run for only 10 min.
Molecular Weight Estimation of the Enzyme
Pressure dialysis was employed not only to purify the aminotransferase,
but also to obtain a crude estimation of the enzymes molecular weight.

On the

F igure 3.

Influence of ribose-5 '-phosphate aminotransferase concentration
on PRA production. The conditions were as described in
"Materials and Methods" and fraction III was employed as the
source of the ribose- 5' - phosphate aminotransferase. At O min.,
only the coupling enzyme was added to the assay system. Each
point on the curve represents an average measurement from two
identical experiments and each point value actually represents an
apparent PRA yield since there was no control subtraction.
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Effect of time on PRA production. The conditions were as
described in "Materials and Methods" and each incubation
system contained 0. 6 pg protein of fraction III. Each point
on the curve represents an average measurement from two
identical experiments.
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basis of the fact that the enzyme would not pass through a filter pad having a
molecular weight exclusion of 100,000, the enzyme was assumed to have a
molecular weight greater than this.

A nearer approximation of the weight was

ascertained by ultracentrifuging a sample of fraction III in a sucrose gradient
according to the method of Noll (46 ).

A value of 229,000

~

12,000) was obtained

(Table 2) where beef liver catalase and bovine hemoglobin were used as references and the molecular weight was calculated from equations derived by Martin
and Ames (41).

Stability of the Enzyme

No systematic studies on the stability of the aminotransferase were
carried out but it was observed that crude, as well as highly purified enzyme
preparations, lost only very slight activity after storage at - 20°c for 8-10
weeks.

Repeated freezing at -20°c and thawing at r oom temperature had no

significant effect on enzyme activity.

Effects of Various Substrates on the Formation of PRA

A series of qualitative and quantitative substrate studies were carried
out with the ribose-5' - phosphate aminotransferase of fraction III and the results
are indicated in Figure 5 and Table 3.

Figure 5 shows the dosage effect of

NH Cl and ribose- 5 1- phosphate on PRA formation.
4

This quantitative test was

composed of two parts , one of which consisted of a series of identical assay
mixtures containing increasing concentrations of ribose-5'-phosphate and a constant concentration of NH Cl and the othe r of which consisted of a series
4
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Table 2.

Molecular weight of ~- typhimurium ribose-5 '-phosphate amino transferase

Protein

Molecular weight

Bovine hemoglobin

68,000

Beef liver catalase

225,000

Ribose-5 '-phosphate aminotransferase

229,000

Note: The procedure is described in "Materials and Methods." The ribose-5'phosphate aminotransferase molecular weight estimation represents an
average determined from two centrifugation runs.

Figure 5.

Influence of the concentration of the substrates on PRA
production. The conditions were as described in "Materials
and Methods" and each incubation mixture contained 0. 4 pg
protein of fraction III. In the NH Cl dosage response test,
4
ribose- 5' - phosphate was maintained at 5 p moles/assay
mixture while the NH Cl concentration was varied from
4
0-50 p- moles/assay mixture and in the ribose-5'-phosphate
dosage response test, NH Cl was maintained at 10 p moles /
4
assay mixture while the ribose-5'-phosphate was varied
from 0-20 \1 moles / assay mixture. Each point on each
curve represents an average measurement from two identical
experiments.
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Table 3. Effect of various amino donors, PP-ribose-P and methionine
sulfoximine on PRA formation
Substrate added

PRA as "total GAR 11
(Nanomoles/ assay syste m)
81. 1

96.0

Carbamyl- P

114. 0

L-Glutamine

153.0

Asparagine

0.0

PP-ribose-P + L-Glutamine

7.2

Methionine Sulfoximine + NH Cl
4

57.7

Note: The conditions were as described in "Materials and Methods" and
each incubation system contained 0. 4 p.g protein of fraction III.
In assay mixtures containing added PP- ribose-P (2 \l- moles / assay
mixture) and L-glutamine (10 }.l. moles / assay mixture), there was
no added ribose- 5 ' -phosphate or NH Cl, all other assay mixtures
contained exogenous ribose- 5 '-phos~ate (5 )1 moles / assay mixture)
and one particular amino donor (10 p. moles / assay mixture). The
concentration of methionine sulfoximine was 0. 5 p- moles / assay
mixture. Each value in the table represents an average measurement from two identical experiments.
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containing increasing concentrations of NH Cl and a constant concentration of
4
ribose-5'-phosphate.

At higher concentrations, ribose-5'-phosphate inhibited

PRA formation, whereas NH 4 Cl chloride did not demonstrate this inhibitory
effect at higher concentrations.

For each concentration of r ibose-5' -phosphate

tested, a control was set up containing that level of the substrate and every other
assay ingredient but fraction III, the same was true for each concentration of
NH Cl tested.
4
A variety of different nitrogen compounds were tested for their ability
to participate as amino donors in PRA synthesis.

L-glutamine was found to be

the best amino donor followed by carbamyl phosphate, (NH ) SO and NH Cl.
4 2 4
4
Asparagine did not serve as an amino donor (Table 3 ).
Because L-glutamine served as such a good amino donor in PRA formation, it seemed possible that the aminotransferase preparation was either
contaminated by PP-ribose-P amidotransferase, whose substrate is L-glutamine,
or the purified preparation contained the amido-rather than the aminotransferase.
To determine, therefore, how much, if any, amidotransferase was present in
the purified extract, NH Cl and ribose-5 '-phosphate were replaced in an
4
incubation mixture by the amidotransferase substrates, L-glutamine and
PP-ribose-P.

The results show that only about 10% as much PRA as "total

GAR" was produced under these circumstances as when ribose-5' -phosphate
and NH Cl were present.
4

This limited PRA production could have been due to a

contamination of fraction III or the coupling agent by low levels of the amidotransferase.

Alternatively fraction III and the coupling agent could have been

free from contamination and the PRA that was detected in the PP-ribose- P
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system could have been produced via the aminotransferase from L-glutamine
and low levels of ribose- 5'-phosphate (ribose-5'-phosphate was probably present
in the commercial PP-ribose-P preparation that was used in the assay).

The

latter hypothesis would suggest, as the substrate tests just mentioned do, that
L-glutamine can substitute for ammonium ion as the amino donor.
To test the adequacy of NH Cl as an amino source for the aminotrans4
ferase reaction, the glutamine synthetase inhibitor, methionine sulfoximine was
employed.

Its presence in an incubation system containing NH Cl as the sole
4

amino donor was used to determine whether NH Cl, itself, was being used as
4
the amino donor or whether the NH Cl was first being converted to L-glutamine.
4
If NH Cl was being used, thePRA reaction would not be inhibited by methionine
4

sulfoximine, but on the other hand, if the NH Cl was first being converted to
4
L-glutamine by the synthetase and the L-glutamine was actually serving as the
amino donor, then the reaction would be inhibited by the sulfoximine.
results of such a test are indicated in Table 3.

The

As can be seen, substantial

amounts of PRA were still formed in the presence of the sulfoximine.

About

70% of the PRA that was produced in the absence of the sulfoximine was still
produced in its presence (81. 1 nanomoles versus 57. 7 nanomoles) . This suggests that NH Cl, itself, serves as an adequate amino source for the amino4
transferase reaction, it also suggests that fraction III primarily contains the
amino rather than the amidotransferase, since the latter has a strict requirement for L-glutamine.
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DISCUSSION

GAR Production in the Coupled System

In the present study, a purine-requiring mutant (pur-D 55) lacking GAR
synthetase (the assay coupling agent) was purposely selected as the source of the
aminotransferase rather than the wild type (LT-2) or another mutant.

Had a

strain been chosen that possessed both the aminotransferase and GAR synthetase
(LT-2 or another mutant), then it would have been impossible to use the coupled
system to assay for the aminotransferase because the GAR produced in the
coupled system in such a case could either have been the result of: (1) the
strain' s synthetase (utilizing non-enzymatically formed PRA), or (2) the strain ' s
aminotransferase (through conversion of the PRA to GAR by the coupling agent):

1) ribose-5'-phosphate + NH Cl non-enzymatically> PRA synthetase )GAR
4
2) ribose-5'-phosphate + NH Cl aminotransferase PRA synthetase;> GAR
4
By utilizing a pur-D extract it was possible to employ the coupled system with
the knowledge that the system was not mistakenly measuring a GAR synthetase
activity of the extract.
That the coupled assay was indeed measuring ribose-5' -phosphate
aminotransferase activity, and not any non-enzymic PRA formation, was
demonstrated in the enzyme dosage-response experiment by the elevated "total
GAR" production which occurred in response to increased fraction III
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concentrations.

The extensively purified enzyme preparation that was employed

had been dialyzed several times so that it could not have contained significant
amounts of the PRA substrates, and consequently the stimulatory dosage effect
could have only been due to high molecular weight material, supposedly enzyme
protein.

But could this enzymatic material have been PP- ribose -P amidotrans -·

ferase, which pur-D mutants do possess (63), or was it truly ribose-5 '-phosphate
aminotransferase? If, in fact, fraction III was comprised of the amidotransferase rather than the aminotransferase, then increasing its dosage in the coupled
system could have lead to the increased "total GAR" production that was noted.
The aminotransferase substrates, ribose-5' -phosphate and NH Cl , could have
4
hypothetically been converted to the amidotransferase substrates, PP-ribose-P
and L-glutamine, by contaminant enzymes either in fraction III or the coupling
agent.

Then any PP-ribose-P amidotransferase present would have converted

these secondary substrates to PRA and the latter would have been converted to
GAR by the coupling agent.

The possibility of fraction III containing the amido-

rather than the aminotransferase seems excluded, however, by the fact that
when ribose-5'-phosphate and NH Cl were substituted by PP-ribose-P and
4
L-glutamine in the coupled system, 90% less "total GAR" was produced than
in the normal system.

In addition, methionine sulfoximine, an indirect

inhibitor of the amidotransferase reaction, only slightly inhibited GAR production
in the normal coupled system (containing fraction III and the aminotransferase
substrates).
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Nierlich and Magasanik (43) observed a non-enzymic formation of PRA
from ribose-5 '-phosphate and ammonium ion in a coupled system of their design ,
but concluded that the reaction was quantitatively insignificant in vivo in A.
aerogenes.

Assuming this to be also true in e_. typhimurium, a close relative

to A. aerogenes, and based upon the above analysis of the present results, it is
concluded that the alternate first step of purine biosynthesis in e_. typhimurium
proceeds enzymically and in a manner similar to that in wheat germ (32),
mammalian tissue (29, 49), E. coli (34) and avian liver (48).

In the latter case,

the alternate enzyme has been partially purified and completely separated from
the L-glutamine dependent amidotransferase.

The reaction mediated by the

avian enzyme requires ammonium ion, ribose-5'-phosphate and magnesium ion,
as does the reaction mediated by thee_. typhimurium enzyme.

The reaction's

overall contribution to purine biosynthesis, however, is still questionable in
both systems.

The Ribose-5' -Phosphate Aminotransferase of
Various Organisms

Reem (48) working with purified avian- liver ribose-5'-phosphate aminotransferase ascertained that NH Cl and (NH ) So served as excellent nitrogen
4
42 4
donors for the avian liver enzyme.

L-glutamine and asparagine were much less

effective and carbamyl-P completely failed to serve as an effective nitrogen
donor.

The e_. typhimurium enzyme shows a somewhat different pattern, as

indicated in Table 3.

L-glutamine and carbamyl-P were the best donors
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followed by (NH ) SO and NH Cl, asparagine was completely ineffective.
4
4 2 4
Although at variance with the avian liver studies, our results coincide almost
exactly with what was found for the aminotransferase of another enteric
bacterium, E. coli (34).
The§_. typhimurium aminotransferase demonstrated the same response
as the avian enzyme to increasing concentrations of the substrates, namely an
inhibition to evelated ribose-5' -phosphate levels and the lack of such to elevated
NH Cl levels.
4

Since ribose-5'-phosphate is not only involved in de novo purine

synthesis but also plays a role in the purine salvage pathway (61), pyrimidine
synthesis (3, 31, 42) and various other biosynthetic routes (39, 54).

It seems

reasonable that its usage would be carefully coordinated and regulated.

As part

of this coordination, there might very likely occur a feed-back inhibition on
ribose-5 '-phosphate aminotransferase in order to restrict the flow of ribose
for de novo purine synthesis.
An 800-fold purification of the §_. typhimurium aminotransferase was
achieved in the present study as compared to a 100-fold purification achieved in
an earlier pigeon liver study by Reem (48).

Substrate studies with both the

purified bacterial (Table 3) and avian (48) enzyme indicate that ribose-5' phosphate, and not PP-ribose-P, serves as the pentose acceptor in the aminotransferase reaction.
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Ribose-5 '-Phosphate Aminotransferase Versus
PP-ribose-P Amidotransferase

PRA can be formed in_§_. typhimurium, not only through the mediation
of ribose-5 '-phosphate aminotransferase but also through the mediation of
PP-ribose-P amidotransferase (15).

The latter enzyme requires PP-ribose-F

and L-glutamine to form PRA, ribose-5 ' -phosphate and NH Cl will not substitute,
4
and the reaction seems to provide the main route for PRA production (17).
The amidotransferase of pigeon liver has a molecular weight of 200,000
(52) and the enzyme readily dissociates into two 100,000 molecular weight
dimers whose monomers have a molecular weight of 50, 000.

The S. typhimurium

aminotransferase has an approximate molecular weight of 229,000.

Perhaps,

the §_. typhimurium ribose-5' -phosphate aminotransferase also dissociates,
since in the second step of purification involving DEAE cellulose chromatography,
two peaks of enzyme activity were observed.

An alternative possibility is that

two isozymes of the aminotransferase exist in_§. typhimurium.

Feed - back Inhibition

Different workers (15, 16, 44, 48, 49, 56, 65) have demonstrated feedback inhibition not only of the classical first step, but also of the alternate first
st ep of de novo purine synthesis.

Purified preparations of pigeon liver amino-

transferase were shown to be inhibited by purines and t heir derivatives, the
nucleotides being more effective than the bases (48).

AMP and ATP at con-

centrations of 4. 0 ,p.M inhibited the enzyme reaction 80 and 87 per cent,
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respectively, whereas GMP at a concentration of 2. 0 mM inhibited the reaction
only 30 per cent.

ATP was ineffective as an inhibitor and AMP-GMP mixtures

exerted no synergistic effect, only an additive one.

The situation is somewhat

different with regard to pigeon liver amidotransferase, here a wider variety of
nucleotides are effective inhibitors at the above concentrations (e.g., AMP,
ADP, ATP, GMP, GDP, and IMP) and AMP-GMP mixtures do exert a
synergistic inhibitory effect (9, 15, 64).

In addition, it was found that the

nucleotides acted as competitive inhibitors of the amidotransferase substrate,
PP-ribose-P.
In bacterial systems, feed-back inhibition of the amidotransferase has

been observed in enzyme extracts from Bacillus subtilis (51, 56), §_. typhimurium
(15, 17) and A. aerogenes (44).

The enzyme from§_. typhimurium is inhibited

by various nucleotides, of which ADP, GMP, GTP, and AMP are the most
effective (15).

A similar pattern of end-product inhibition has been observed

with the partially purified enzyme from .f. coli (15, 34) and it was suggested
that the ATP/ADP ratio might be of primary importance.

CONCLUSIONS

1.

In vitro kinetic studies indicate that part, if no1 most, of the /J-D-phosphoribosylamine (PRA) synthesized from ribose-5' -phosphate and ammonium
ion in_§. typhimurium is formed enzymically rather than non-enzymically.

2.

The involved enzyme, ribose-5'-phosphate aminotransferase, has been
purified about 800..fold from extracts of§_. typhimurium (pur D-55) and is
distinct from ribosy lpyrophosphate 5 '-phosphate amidotransf erase (EC
2. 4. 1. 14) which is found in the same organism, but which catalyzes the
formation of PRA from PP-ribose-P and L-glutamine.

3.

The most highly purified preparation of the aminotransferase (fraction III)
was either uncontaminated by the amidotransferase or was contaminated
by only very small quantities of the enzyme.

4.

Alternate amino donors for the aminotransferase reaction, in the order of
decreasing effectiveness, include: L-glutamine, carbamyl-phosphate,
(NH ) so and NH Cl.
4 2 4
4

5.

L-asparagine would not serve as an amino donor.

Ammonium ion could be used directly as an amino donor in the aminotransferase reaction without prior conversion to L-glutamine.

6.

The aminotransferase was not inhibited by higher concentrations of NH Cl,
4
but was drastically inhibited by higher concentrations (above 5 )1 moles/
assay mixture) of ribose-5' -phosphate.
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7.

The aminotransferase has an approximate molecular weight of 229,000

(.±:. 12,000) as determined by ultrafiltration and sucrose gradient ultracentrifugation.
8. A coupled assay, employing a partially purified GAR synthetase extract
from another §_. typhimurium strain as the source of the coupling agent ,
was used to measure the enzyme.

For unknown reasons, PRA pr oduction

decreased after 10 min. incubation at 37°C in this system.
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